The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. - Wikidata - awgldk - TriplyDB

The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

http://www.wikidata.org/entity/Q38261369

about

Therapeutic Applications of Rose Hips from Different Rosa Species.VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.(+)-Catechin in a 1:2 Complex with Lysine Inhibits Cancer Cell Migration and Metastatic Take in Mice.Overcoming resistance to cetuximab with honokiol, a small-molecule polyphenol.Redox control of cancer cell destruction.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.

P2860

Q33838470-502CE9C6-DCFB-40D0-90F0-425D1DF3991A Q35698934-CC6B2561-D774-4248-AB50-B62FECF8C597 Q36782461-4388EF63-CB83-49C4-A51C-572DB57B78A1 Q37022420-2B1CB9C3-09FB-4076-B960-37CF6083B17C Q38854862-D3048FAB-382D-41C8-A7C0-026B4C79C972 Q39077570-5B28073E-8B85-4EA1-B6D0-2E87DA0857AE Q39344275-60340103-7D85-4410-8F61-B09AB70ED957 Q46237031-7E4F994D-48FD-4BAD-A0AF-DBFA2B8C90BD Q46278768-1719821B-6BEE-4C53-89A0-9CD1781646A4 Q51748168-A9207F4C-737D-4D8C-B8BB-55486BB8ECD3 Q55503143-E038F33E-5008-4003-A375-6E50C4D7DC88

P2860

The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

http://www.wikidata.org/entity/Q38261369

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

The antioxidant paradox: what ...... herapeutic context for cancer.

@en

type

label

The antioxidant paradox: what ...... herapeutic context for cancer.

@en

prefLabel

The antioxidant paradox: what ...... herapeutic context for cancer.

@en

P1433

Q38261369-41B53F52-A2C5-41AC-9CF8-02BFBDEB0466

P1476

Q38261369-B31C46DF-D7E0-45CD-87C4-1CEB6F9422E2

P2093

Q38261369-ABEBB7E7-8166-42B3-B40D-79F03AB88AD7

Q38261369-D095AF04-4129-470C-BC9B-070059AF2401

P2860

Q38261369-00F38A9C-7F09-4833-94E7-708123CFA9B8

Q38261369-056E1AC4-94A7-49BC-AF5E-96956870B834

Q38261369-0A851653-FA8C-4AAC-9DD8-C802F1374321

Q38261369-0DCAB62D-5094-4B4D-9FC1-7276A99E5D3D

Q38261369-0E25FE5F-6C52-4984-AD71-0481BC4E489C

Q38261369-0E4839D0-C586-48D0-BC0E-B62DD6798846

Q38261369-16D6E067-02B4-4D1D-976C-75308CF056B8

Q38261369-18CF3ECF-2583-4D6B-8C01-D69ECAEC3470

Q38261369-23CD6485-B34F-4461-9745-715622CFDC0C

Q38261369-2789636A-1B0C-45E8-A281-FB34465EAEF0

P304

Q38261369-1D1059B3-616A-4D75-9640-C737B20243BE

P31

Q38261369-054A4308-BC9A-491A-AF8F-129057BCFD48

P356

Q38261369-89BB4FE2-9E18-4813-90DF-6338786F45FF

P433

Q38261369-83D0AC01-D46C-48F3-B02D-1C5A0BC3D606

P478

Q38261369-18DFFDB6-5309-4494-B6A4-6F11A6B550D0

P577

Q38261369-9F226AB8-9984-477F-9102-377DDF02310D

P5875

Q38261369-23F93B65-28F4-4F5B-8D5A-4BF3CBF760DA

P698

Q38261369-3947BF84-7368-4582-9F5F-66A60C976A63

P932

Q38261369-554C4C18-EE42-48E1-B2F1-90015FA59993

P356

P1433

Future Medicinal Chemistry

P1476

The antioxidant paradox: what ...... herapeutic context for cancer.

@en

P2093

Jack L Arbiser

http://www.w3.org/2001/XMLSchema#string

Michael Y Bonner

http://www.w3.org/2001/XMLSchema#string

P2860

Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

Honokiol, a multifunctional antiangiogenic and antitumor agent

Targeting NADPH oxidases for the treatment of cancer and inflammation

Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1

Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells

P304

1413-1422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.14.86

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267103094

http://www.w3.org/2001/XMLSchema#string

P698

25329197

http://www.w3.org/2001/XMLSchema#string

P932

4412352

http://www.w3.org/2001/XMLSchema#string